UK-based AI biotechnology company Kuano has raised GBP 1.8 million (~USD 2.4 million) in a seed funding round led by Mercia Ventures, with participation from ACF Investors, Ascension Ventures, o2h Ventures, Meltwind Advisory LLP, and other angel investors. This brings the total funds raised by the company to GBP 2.8 million (~USD 3.5 million).
The proceeds will support the growth and validation of Kuano's platform for enzyme-targeted drug discovery, strengthen the management team, and prepare the company for scaling.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.